| Year |
Citation |
Score |
| 2021 |
Contreras-Trujillo H, Eerdeng J, Akre S, Jiang D, Contreras J, Gala B, Vergel-Rodriguez MC, Lee Y, Jorapur A, Andreasian A, Harton L, Bramlett CS, Nogalska A, Xiao G, Lee JW, et al. Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses. Nature Communications. 12: 6522. PMID 34764253 DOI: 10.1038/s41467-021-26771-1 |
0.317 |
|
| 2015 |
Cheah MT, Chen JY, Sahoo D, Contreras-Trujillo H, Volkmer AK, Scheeren FA, Volkmer JP, Weissman IL. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proceedings of the National Academy of Sciences of the United States of America. 112: 4725-30. PMID 25825750 DOI: 10.1073/Pnas.1424795112 |
0.631 |
|
| 2014 |
Rinkevich Y, Montoro DT, Contreras-Trujillo H, Harari-Steinberg O, Newman AM, Tsai JM, Lim X, Van-Amerongen R, Bowman A, Januszyk M, Pleniceanu O, Nusse R, Longaker MT, Weissman IL, Dekel B. In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration. Cell Reports. 7: 1270-83. PMID 24835991 DOI: 10.1016/J.Celrep.2014.04.018 |
0.532 |
|
| 2013 |
Tseng D, Volkmer JP, Willingham SB, Contreras-Trujillo H, Fathman JW, Fernhoff NB, Seita J, Inlay MA, Weiskopf K, Miyanishi M, Weissman IL. Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proceedings of the National Academy of Sciences of the United States of America. 110: 11103-8. PMID 23690610 DOI: 10.1073/Pnas.1305569110 |
0.596 |
|
| 2013 |
Edris B, Willingham SB, Weiskopf K, Volkmer AK, Volkmer JP, Mühlenberg T, Montgomery KD, Contreras-Trujillo H, Czechowicz A, Fletcher JA, West RB, Weissman IL, van de Rijn M. Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth. Proceedings of the National Academy of Sciences of the United States of America. 110: 3501-6. PMID 23382202 DOI: 10.1073/Pnas.1222893110 |
0.635 |
|
| 2012 |
Edris B, Weiskopf K, Volkmer AK, Volkmer JP, Willingham SB, Contreras-Trujillo H, Liu J, Majeti R, West RB, Fletcher JA, Beck AH, Weissman IL, van de Rijn M. Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. Proceedings of the National Academy of Sciences of the United States of America. 109: 6656-61. PMID 22451919 DOI: 10.1073/Pnas.1121629109 |
0.565 |
|
| 2012 |
Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, et al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proceedings of the National Academy of Sciences of the United States of America. 109: 6662-7. PMID 22451913 DOI: 10.1073/Pnas.1121623109 |
0.61 |
|
| 2012 |
Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, Willingham SB, Pazhanisamy SK, Contreras-Trujillo H, Storm TA, Lotan Y, Beck AH, Chung BI, Alizadeh AA, Godoy G, et al. Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proceedings of the National Academy of Sciences of the United States of America. 109: 2078-83. PMID 22308455 DOI: 10.1073/Pnas.1120605109 |
0.619 |
|
| 2012 |
Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, Willingham SB, Pazhanisamy SK, Contreras-Trujillo H, Storm TA, Lotan Y, Beck AH, Chung BI, Alizadeh AA, Godoy G, et al. Three differentiation states risk-stratify bladder cancer into distinct subtypes (Proceedings of the National Academy of Sciences of the United States of America (2012) 109, 6 (2078-2083) DOI: 10.1073/pnas.1120605109) Proceedings of the National Academy of Sciences of the United States of America. 109: 3600. DOI: 10.1073/Pnas.1201493109 |
0.506 |
|
| 2012 |
Leman E, Huang W, Contreras-Trujillo H, Volksmer J, Willingham S, Barron A, Gonzalgo M. 1072 INHIBITION OF BLADDER CANCER CELL GROWTH BY TREATMENT WITH SYNTHETICALLY DERIVED ANTI-CANCER PEPTOIDS Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1178 |
0.485 |
|
| Show low-probability matches. |